AbbVie (prior sponsor, Abbott)
abbvie.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
223
Active
0
Phase 3
45
Total enrollment
141,830
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Rheumatoid Arthritis27
- Secondary Hyperparathyroidism11
- Psoriasis10
- Chronic Hepatitis C Infection10
- Psoriatic Arthritis8
- Chronic Kidney Disease8
- Ankylosing Spondylitis8
- Crohn's Disease8
Frequently asked questions about AbbVie (prior sponsor, Abbott)
- How many clinical trials does AbbVie (prior sponsor, Abbott) have on ClinicalTrials.gov?
- AbbVie (prior sponsor, Abbott) is listed as the lead sponsor on 223 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of AbbVie (prior sponsor, Abbott)'s trials are in Phase 3?
- 45 of AbbVie (prior sponsor, Abbott)'s trials are in Phase 3.
- What therapeutic areas does AbbVie (prior sponsor, Abbott) focus on?
- AbbVie (prior sponsor, Abbott)'s most-studied conditions on ClinicalTrials.gov are Rheumatoid Arthritis, Secondary Hyperparathyroidism, Psoriasis, Chronic Hepatitis C Infection, Psoriatic Arthritis.